SOURCE: Novus Acquisition & Development Corp

August 25, 2014 08:00 ET

Novus Executes Provider Agreement With MMJ Beverage Company, Nana's Secret

MIAMI, FL--(Marketwired - Aug 25, 2014) - Novus Acquisition & Development Corp. (PINKSHEETS: NDEV) ("Novus"), developer of healthcare/insurance solutions targeting the medical marijuana industry through its wholly owned subsidiary Novus Medical Group, Inc., today announced the execution of an Exclusive Provider Agreement with Nana's Secret, LLC located in the State of Washington. Under the terms of the agreement, patients enrolled in the company's Novus MedPlan Benefit Package will receive an exclusive 30% discount on Nana's Secret full line of products.

"We are very excited to add Nana's Secret to the Novus MedPlan network," said Novus CEO Frank Labrozzi. "With many medical marijuana patients paying hundreds or thousands of dollars per month, the Novus MedPlan network aims to make these medications more affordable by providing exclusive concessions on high-quality products. The addition of Nana's Secret represents a key milestone as we expand the program into new states and reach new patients with affordable solutions."

Nana's Secret develops and markets cannabis-infused soft drinks that are available in six different flavors and contain high-grade cannabis extracts, providing a smokeless alternative for legal cannabis consumption. After battling epilepsy and arthritic pain with little success, Cecilia Siverston ("Nana") founded the company to ease suffering and provide immediate relief after spending over a year researching the optimal formula. As with the Charlotte's Web strain of medical marijuana, the word has spread and Nana's Secret Soda is now highly sought after in Seattle area dispensaries.

"I still have epilepsy and I drink my soda every day," said Nana's Secret CEO Cecilia Siverston. "Without my cannabis soda, I would not be able to function as a 'normal' person. With cannabis being the only difference, I have found there are no terrible side effects from the prescription drugs that I have taken for over 30 years." On another note Cecilia Siverton has such a passion she is now addressing epileptic issues in children by donating some of the proceeds from sales of Nana's Secret to the National Epilepsy Foundation.

With these milestones being achieved, Novus plans to roll out Novus MedPlan on October 15, 2014 and patients can pre-enroll now without cost and receive one month free in states that have MMJ legislation passed or on the ballot on November 4, 2014 at http://novusmedicalgroup.com/preenrollment.htm

About Nana's Secret

Nana's Secret formulates and manufacturers cannabis-infused soft drinks and edibles. The company has RCW 69.51 A and a I-502 compliance. Learn more by visiting the company's website at www.nanassecret.com.

About Novus

Novus Acquisition & Development Corp. ("Novus") provides health insurance and related insurance solutions to the medical marijuana industry in states where legal programs exist with up to 50% saving on our network approved products. The Company also plans to offer physicians' education programs, pharmaceutical R&D, compliance, and business development services within the industry.

NDEV will work as outside developers and will not cultivate, handle, transport grow, extract, dispense put up for sale, put on the market, vend, deliver, supply, circulate, trade, cannabis or any substances that violates the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The products and statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on this press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional.

The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government's enforcement of current federal laws could cause significant financial changes to the Company. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

Safe Harbor

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information